Michael Fabrizio MD, FACS, CEO, Urology of Virginia, Professor of Urology Eastern Virginia Medical School
Advertisement
Articles by Michael Fabrizio MD, FACS, CEO, Urology of Virginia, Professor of Urology Eastern Virginia Medical School
Advertisement
Latest Updated Articles
- Long-term Survival with Immunotherapy in Advanced Prostate Cancer
September 4th 2019
Advertisement
Advertisement
Trending on Urology Times
1
The Evolving Landscape of Minimally Invasive BPH Therapy
2
TURP, HoLEP, and the Future of Minimally Invasive BPH Therapy
3
FDA grants priority review to perioperative durvalumab plus enfortumab vedotin in MIBC
4
FDA approves belzutifan plus lenvatinib for advanced clear cell renal cell carcinoma
5